NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $221,800 | +4.9% | 2,198 | -4.4% | 0.02% | 0.0% |
| Q1 2023 | $211,416 | -3.0% | 2,298 | -4.4% | 0.02% | -7.7% |
| Q4 2022 | $218,001 | -2.2% | 2,403 | -8.9% | 0.03% | -3.7% |
| Q2 2022 | $223,000 | -4.3% | 2,638 | -0.5% | 0.03% | +17.4% |
| Q1 2022 | $233,000 | -27.0% | 2,651 | -27.2% | 0.02% | -25.8% |
| Q4 2021 | $319,000 | +1.9% | 3,640 | -4.9% | 0.03% | -3.1% |
| Q3 2021 | $313,000 | -19.9% | 3,827 | -10.7% | 0.03% | -20.0% |
| Q2 2021 | $391,000 | -26.8% | 4,287 | -31.3% | 0.04% | -31.0% |
| Q1 2021 | $534,000 | -89.0% | 6,240 | -87.9% | 0.06% | -89.5% |
| Q4 2020 | $4,855,000 | +8.3% | 51,417 | -0.2% | 0.56% | -2.1% |
| Q3 2020 | $4,482,000 | +0.1% | 51,536 | +0.5% | 0.57% | -5.0% |
| Q2 2020 | $4,479,000 | +11.9% | 51,275 | +5.6% | 0.60% | -2.3% |
| Q1 2020 | $4,004,000 | -12.9% | 48,558 | +0.0% | 0.61% | +9.5% |
| Q4 2019 | $4,596,000 | +8.2% | 48,538 | -0.7% | 0.56% | -0.5% |
| Q3 2019 | $4,248,000 | -6.2% | 48,881 | -1.4% | 0.56% | -7.4% |
| Q2 2019 | $4,528,000 | -5.4% | 49,592 | -0.4% | 0.61% | -4.3% |
| Q1 2019 | $4,787,000 | +11.0% | 49,788 | -0.9% | 0.63% | +11.2% |
| Q4 2018 | $4,312,000 | +0.3% | 50,243 | +0.7% | 0.57% | +16.4% |
| Q3 2018 | $4,297,000 | +11.4% | 49,875 | -2.3% | 0.49% | +6.1% |
| Q2 2018 | $3,856,000 | -23.5% | 51,042 | -18.1% | 0.46% | -24.8% |
| Q1 2018 | $5,039,000 | -1.4% | 62,319 | +2.3% | 0.61% | -1.1% |
| Q4 2017 | $5,112,000 | +5.0% | 60,894 | +7.4% | 0.62% | -4.0% |
| Q3 2017 | $4,868,000 | +1602.1% | 56,703 | +1554.1% | 0.65% | +1475.6% |
| Q2 2017 | $286,000 | +13.5% | 3,428 | +0.9% | 0.04% | +7.9% |
| Q1 2017 | $252,000 | +70.3% | 3,398 | +67.6% | 0.04% | +46.2% |
| Q4 2016 | $148,000 | -7.5% | 2,028 | 0.0% | 0.03% | -10.3% |
| Q3 2016 | $160,000 | -17.1% | 2,028 | -13.4% | 0.03% | -17.1% |
| Q2 2016 | $193,000 | +28.7% | 2,343 | +13.6% | 0.04% | +29.6% |
| Q1 2016 | $150,000 | -15.3% | 2,062 | 0.0% | 0.03% | -15.6% |
| Q4 2015 | $177,000 | -6.8% | 2,062 | 0.0% | 0.03% | -13.5% |
| Q3 2015 | $190,000 | -2.6% | 2,062 | +3.8% | 0.04% | +8.8% |
| Q2 2015 | $195,000 | -3.0% | 1,987 | -2.5% | 0.03% | -5.6% |
| Q1 2015 | $201,000 | -1.0% | 2,037 | -6.9% | 0.04% | -2.7% |
| Q4 2014 | $203,000 | -3.3% | 2,187 | -2.2% | 0.04% | -5.1% |
| Q3 2014 | $210,000 | +3.4% | 2,237 | 0.0% | 0.04% | +14.7% |
| Q2 2014 | $203,000 | +13.4% | 2,237 | +6.4% | 0.03% | +13.3% |
| Q1 2014 | $179,000 | +11.9% | 2,102 | +5.3% | 0.03% | +11.1% |
| Q4 2013 | $160,000 | +28.0% | 1,996 | +23.1% | 0.03% | +22.7% |
| Q3 2013 | $125,000 | -5.3% | 1,622 | -13.6% | 0.02% | -8.3% |
| Q2 2013 | $132,000 | – | 1,877 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |